In other studies, it was shown that pathways that can regulate the EMT process, such as phosphorylated EGFR, HIF1α, HER2 and PI3K/Akt signaling, are expressed or activated in CTCs of women with breast cancer [153,154]. Here, ERBB2 is linked to breast carcinoma.